Clinical and prognostic value of discrepancies in microsatellite dna regions between recipient and donor in human leukocyte antigen-identical allogeneic transplantation setting

Transplantation

Volumn 86, Issue 7, 2008, Pages 983-990

  Alcoceba, Miguel ^a   Balanzategui, Ana ^a   Díez Campelo, Maria ^a   Martín Jiménez, Patricia ^a   Sarasquete, Maria Eugenia ^a   Chillón, M Carmen ^a   Santamaría, Carlos ^a   Pérez Simón, Jose Antonio ^a   Marín, Luis ^a   Caballero, M Dolores ^a   San Miguel, Jesús F ^a   García Sanz, Ramón ^a   González, Marcos ^a  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

Graft versus host disease; Microsatellite DNA regions; Short tandem repeats; Stem cell transplantation

Indexed keywords

BUSULFAN; CYCLOSPORIN A; FLUDARABINE; HLA ANTIGEN; MELPHALAN; METHOTREXATE; MICROSATELLITE DNA; SATELLITE DNA;

ADOLESCENT; ADULT; AGED; ALLELE; ALLOTRANSPLANTATION; ARTICLE; DISEASE SEVERITY; DONOR; DOSE RESPONSE; DRUG EFFICACY; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYELOPROLIFERATIVE DISORDER; PRIORITY JOURNAL; PROGNOSIS; RECIPIENT; RISK FACTOR; SHORT TANDEM REPEAT; SIBLING; STEM CELL; BLOOD DISEASE; GENETICS; INCIDENCE; RISK ASSESSMENT; SURVIVAL; SURVIVOR; TREATMENT OUTCOME;

DNA, SATELLITE; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HLA ANTIGENS; HUMANS; INCIDENCE; MICROSATELLITE REPEATS; PROGNOSIS; RISK ASSESSMENT; SURVIVAL ANALYSIS; SURVIVORS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 56049123874     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318183ee2a     Document Type: Article

References (27)

1. Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med 2006; 354: 1813.
2. Ferrara JL, Deeg HJ. Graft-versus-host disease. N Engl J Med 1991; 324: 667.
3. ReddyP,Ferrara JL. Immunobiologyofacute graft-versus-host disease. Blood Rev 2003; 17: 187.
4. Baron F, Storb R. Hematopoietic cell transplantation after reduced-intensity conditioning for older adults with acute myeloid leukemia in complete remission. Curr Opin Hematol 2007; 14: 145.
5. Flomenberg N, Baxter-Lowe LA, Confer D, et al. Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatchingisassociated with a strong adverse effect on transplantation outcome. Blood 2004; 104: 1923.
6. Goulmy E, Schipper R, Pool J, et al. Mismatches of minor histocom-patibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. N Engl J Med 1996; 334: 281.
7. HambachL, Spierings E, Goulmy E. Risk assessment in haematopoietic stem cell transplantation: Minor histocompatibility antigens.Best Pract Res Clin Haematol 2007; 20: 171.
8. Chao NJ. Minors come of age: Minor histocompatibility antigens and graft-versus-host disease. Biol Blood Marrow Transplant 2004; 10: 215.
9. Lin MT, Storer B, Martin PJ, et al. Relation of an interleukin-10 pro- moter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation. N Engl J Med 2003; 349: 2201.
10. Dickinson AM, Charron D. Non-HLA immunogenetics in hematopoietic stem cell transplantation. Curr Opin Immunol 2005; 17: 517.
11. Middleton PG, Taylor PR, Jackson G, et al. Cytokine gene polymorphisms associating with severe acute graft-versus-host disease in HLA-identical sibling transplants. Blood 1998; 92: 3943.
12. Rocha V, Porcher R, Filion A, et al. Association of pharmacogenes polymorphisms with toxicities and GvHD after HLA-identical sibling bone marrow transplantation [abstract]. Blood 2003; 102: 848.
13. Holler E, Rogler G, Herfarth H, et al. Both donor and recipient NOD2/ CARD15 mutations associate with transplant-related mortality and GvHD following allogeneic stem cell transplantation. Blood 2004; 104: 889.
14. Gonzalez M, Lopez-Perez R, Garcia-Sanz R, et al. Debate round-table: Comments concerning chimerism studies. Leukemia 2001; 15: 1986.
15. Kreyenberg H, Holle W, Mohrle S, et al. Quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection: The Tuebingen experience. Leukemia 2003; 17: 237.
16. Alcoceba M, Díez-Campelo M, Martín-Jimenez P, et al. Allogeneic transplantation with identical MHC: Clinic-prognostic value of discrepancies of microsatellite DNA regions between recipient and donor [abstract]. Blood 2004; 104:3336.
17. Dalva K, Arat M, Serbest E, et al. A comparison of the number of informative short tandem repeat (STR) loci between HLA identical donor-recipient pairs and the frequency of graft versus host disease (GvHD) [abstract]. Genes Immun 2004; 5: 91.
18. Stern M, Meyer-Monard S, Bucher C, et al. Prognostic value of discrepancies in micro-satellite DNA regions between donor and recipient in allogeneic stem cell transplantation [abstract]. Bone Marrow Transplant 2005; 35: 249.
19. Kim DH, Jung HD, Kwack DH, et al. Predicting outcomes of HLA-identical allogeneic stem cell transplants from variable number of tandem repeat disparity between donors and recipients. Haematologica 2006; 91: 71.
20. Perez-Simon JA, Diez-Campelo M, Martino R, et al. Influence of the intensity of the conditioning regimen on the characteristics of acute and chronic graft-versus-host disease after allogeneic transplantation. Br J Haematol 2005; 130: 394.
21. Martino R, Caballero MD, Canals C, et al. Allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning: Results of a prospective multicentre study. Br J Haematol 2001; 115: 653.
22. Perez-Simon JA, Diez-Campelo M, Martino R, et al. Impact of CD34+ cell dose on the outcome of patients undergoing reduced-intensity-conditioning allogeneic peripheral blood stem cell transplantation. Blood 2003; 102: 1108.
23. Przepiorka D, Weisdorf D, Martin P, et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995; 15: 825.
24. Perez-Simon JA, Sanchez-Abarca I, Diez-Campelo M, et al. Chronic graft-versus-host disease: Pathogenesis and clinical management. Drugs 2006; 66: 1041.
25. Gonzalez M, Gonzalez D, Lopez-Perez R, et al. Heteroduplex analysis of VDJ amplified segments from rearranged IgH genes for clonality assessments in B-cell non-Hodgkin's lymphoma. A comparison between different strategies. Haematologica 1999; 84: 779.
26. Watzinger F, Lion T, Steward C. The RSD code: Proposal for a nomenclature of allelic configurations in STR-PCR-based chimerism testing after allogeneic stem cell transplantation. Leukemia 2006; 20: 1448.
27. Excoffier L, Laval G, Schneider S. Arlequin ver. 3.0: An integrated software package for population genetics data analysis. Evol Bioinform Online 2005; 1: 47